Pain after hysteroscopic surgery in gynecological diseases.
Conditions
Interventions
Intervention 1: Intervention group: Dilute rupivacaine (10 cc of half a percent rupivacaine per 1000 cc of normal saline per liter) is given as a dilating fluid during hysteroscopy. Intervention 2: Co
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: Women candidates for hysteroscopy treatment based on the opinion of a specialist Conscious consent to participate in the study
Exclusion criteria
Exclusion criteria: Existence of pelvic inflammatory disease Having known cervical malignancy, severe uterine bleeding, cervical conization Need for intraoperative surgery due to complications (such as laparotomy due to uterine perforation) Having psychological or neurological disorders that affect pain perception. Allergy to rupivacaine Reluctance to continue cooperation while studying Patients with chronic diseases with pain such as low back pain, etc. who use continuous painkillers. Patients have previously had a tubectomy or have a bilateral obstruction of the tube. Patients with preoperative pelvic pain, dyspareunia, dysmenorrhea, with a vas score of 3 or higher.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intensity and frequency of pain. Timepoint: 6, 12, 24 and 48 hours after hysteroscopy. Method of measurement: Questionnaire and patient file. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactKobra Tahermanesh
Iran University of Medical Sciences
Outcome results
None listed